Chelation Therapy
Potenziativa ®
Chelation Therapy
When metals like lead, mercury, aluminum, and arsenic build up in your body, they can be toxic. Chelation therapy is a specific medical treatment to remove these metals so that they do not pose a problem for the health of the individual.
How chelation therapy works
Chelation therapy uses special synthetic amino acids (EDTA, DMPS and DMSA) that bind to the metals present in the blood and are then eliminated in the urine. The chelation therapy with EDTA is carried out intravenously (IV therapy) through a common slow drip infusion which has an average duration between two and three hours. Generally, a cycle of sessions is followed with frequency once a week for at least five weeks, a period necessary to highlight the first benefits for the patient. Orally it can be carried out with molecules, taken in the form of capsules in galenic preparation, such as DMPS and DMSA which, between them, have an affinity for different heavy metals. Once these molecules bind the toxic metals, the body eliminates them in the form of a complex (chelating agent / metal) through the urine.
Metals that can be removed with chelation therapy include lead, mercury, arsenic, aluminum, cadmium, and many others. Before carrying out this treatment, the doctor performs a blood test to especially assess kidney function and blood calcium as well as make sure through a test carried out on the urine (chelation test) or the hair (mineralogram of the hair) that the presence of high levels of heavy metals.
What other clinical conditions can be treated?
- The use of chelation therapy to treat this condition is based on the hypothesis that autism is caused by mercury in vaccines received in childhood. Current studies have not supported this hypothesis but some doctors argue that removing heavy metals from the body can improve the symptoms of autism. The American Academy of Pediatrics (AAP) also states that there is no evidence that chelation therapy is an effective treatment for autism and does not recommend its use in this condition, except in clinical studies aimed at research.
- Alzheimer’s disease. In patients who have this condition, abnormal proteins called tau and beta amyloid build up in the brain and damage it. To date, no treatment can stop or reverse the course of this disease. Some researchers think that an accumulation of metals such as copper, iron, zinc and aluminum could also play a role in the genesis and progression of Alzheimer’s. For this reason, chelating therapy would have a rational application in treating this pathology but so far there are not enough clinical trials to say that it works.
- Atherosclerosis. It consists of the formation of fat and calcium deposits in the artery wall called plaques (atherosclerotic plaques). These formations constrict blood vessels making them less flexible and thus interfering with normal blood flow. They can also trigger the formation of thrombi and emboli. Arterial plaques contain calcium. Disodium EDTA, a substance used in intravenous chelation therapy, binds to this mineral. The hypothesis put forward by the researchers is that chelation therapy reduces the levels of calcium accumulated in the blood vessel wall, also reducing the formation of plaques. In 2002, the National Institutes of Health conducted a large chelation therapy study called TACT (Trial to Assess Chelation Therapy). He found that this treatment somewhat reduced the risk of heart attacks, strokes and other heart problems. But it only worked in people with diabetes. The study didn’t find enough evidence that it cures heart disease. So far, the FDA has not approved this therapy for that condition. A new ongoing clinical trial called TACT2 could provide more information by 2023.
Side effects
When chelation therapy is carried out in accordance with the protocols and for a justified therapeutic purpose, it can be safe. The side effect that can occur is inflammation of the vein in which the drip is administered, which is common in any intravenous therapy. You could also have fever, headache, nausea and vomiting.
Chelating drugs can bind and remove certain metals or trace elements that the body needs, such as calcium, copper and zinc. This can lead to a lack of these important substances therefore, during the therapeutic cycle, it is advisable to reintegrate them in a mix with other trace elements, orally. Before carrying out the therapy, the doctor must evaluate some blood tests such as, in particular, blood calcium and creatinine (renal function) and have the patient sign an informed consent.
Programs
ENERGY & VITALITY
Potenziativa ®
PREVENTION & HEALTHY AGING
Potenziativa ®
WEIGHT LOSS
Potenziativa ®
MEDICAL DETOX
Potenziativa ®
IV THERAPY
Potenziativa ®
Via Primo Tatti 1 B
22100 Como – IT
P.I.03763540139
REA: Co-331788
PEC: medwellness@legalmail.it
